Clinical Trial

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

Name: Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer — clinical trial record (NCT07673016)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: INSITE

Recruiting

View on ClinicalTrials.gov →

Summary

This is a prospective, multicenter observational study designed to collect urine and tumor biospecimens and associated clinical data from patients undergoing evaluation, treatment, or surveillance for urothelial carcinoma.

Trial Details

NCT Number	NCT07673016
Lead Sponsor	Convergent Genomics, Inc.
Conditions	Bladder Cancer, Urothelial Carcinoma (UC), Hematuria, Upper Tract Urothelial Cancer
Enrollment	2,500 participants
Start Date	2019-10-15
Primary Completion	2034-12 (estimated)
Study Completion	2034-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-29